

Cover Story
White House
By Alice Tracey and Matthew Bin Han Ong
In Brief


Clinical Roundup
Drugs & Targets
NCI Trials


NCI Trials for February 2022
The National Cancer Institute approved the following clinical research study last month.
Trending Stories
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism
Experts call the move “extremely premature” - Bhattacharya: New grant review criterion is “not political”
- Population-based cancer surveillance is a national treasure at risk
- Congress seems to have NCI’s back—is cautious optimism warranted? Two former directors say yes.
- ACOG says it will no longer accept federal funding